Skip to content

Salt: blood pressure elevation, alternative assessments and taste sensitivity

Can the immediate pressor response to oral salt be used as an alternative method to assess salt sensitive blood pressure, alongside other known blood pressure related clinical assessments?

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14162385
Enrollment
300
Registered
2026-07-14
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension Circulatory System

Interventions

Simple randomisation using SPSS Software to either: Index test: immediate pressor response to oral salt (IPROS): After an 8-hour overnight fast, IPROS data will be collected. Briefly, blood pressure

Sponsors

Lake Lucerne Institute (LLUI)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
21 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Aged 21–50 years, the cut off at age 50 years is related to the association of increased age with salt sensitivity and arterial wall thickening. 2. Participants must have been residing in Europe for more than one year. This cutoff is selected to account for the acculturation effect. 3. Both male and female participants will be recruited, sex will be used as a covariate in all following analysis. Sex is known to influence blood pressure, but difference in the prevalence of salt sensitive blood pressure are unknown. Although sex comparison is not an aim of this study, sex differences will be taken into consideration. 4. All participants are required to be able to give informed consent as documented by signature. 5. Participants in Switzerland must be able to understand English, German or Italian, participants in the UK must be able to understand English, and participants in Italy must be able to understand English or Italian.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating 2. Diagnosed hypertension or other conditions known to influence blood pressure (e.g. advanced chronic kidney disease, heart failure, secondary hypertension). 3. Participants must not be taking any blood pressure regulating medication. Blood pressure medication will impact response to dietary salt. 4. Participants must not have a resting blood pressure of higher than 130/80 mmHg.

Design outcomes

Primary

MeasureTime frame
Area under the receiver operating characteristic curve (AUROC) value of IPROS compared to the reference methodology measured using the salt sensitivity classifications (mean arterial pressure change or percentage change between diets) at 255 participants completing the entire protocol

Secondary

MeasureTime frame
The influence of salt taste profile on salt taste sensitivity measured using recognition and detection threshold and liking and intensity, at 255 participants completing the IPROS protocol and after the entire study protocol;The association of IPROS with short-term blood pressure-related risk factors of cardiovascular disease (CVD) measured using mean arterial pressure and blood pressure at 55 participants completing the IPROS protocol and after the entire study protocol;The association of IPROS and salt sensitivity with genetic variations measured using genetic analysis at 255 participants completing the IPROS protocol and after the entire study protocol

Countries

England, Italy, Switzerland, United Kingdom

Contacts

Public ContactCatherine Graham
cat.graham@llui.org+41 (0)795263836

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Aug 10, 2026